226 related articles for article (PubMed ID: 35563301)
41. Primary sclerosing cholangitis associated colitis: Characterization of clinical, histologic features, and their associations with liver transplantation.
Aranake-Chrisinger J; Dassopoulos T; Yan Y; Nalbantoglu I
World J Gastroenterol; 2020 Jul; 26(28):4126-4139. PubMed ID: 32821074
[TBL] [Abstract][Full Text] [Related]
42. Colectomy for patients with ulcerative colitis and primary sclerosing cholangitis - what next?
Block M; Jørgensen KK; Oresland T; Lindholm E; Grzyb K; Cvancarova M; Vatn MH; Boberg KM; Börjesson L
J Crohns Colitis; 2014 May; 8(5):421-30. PubMed ID: 24239402
[TBL] [Abstract][Full Text] [Related]
43. The impact of ulcerative colitis on the long-term outcome of patients with primary sclerosing cholangitis.
Navaneethan U; Venkatesh PG; Lashner BA; Shen B; Kiran RP
Aliment Pharmacol Ther; 2012 May; 35(9):1045-53. PubMed ID: 22428605
[TBL] [Abstract][Full Text] [Related]
44. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.
Bjarnason I; Hayee B; Pavlidis P; Kvasnovsky C; Scalori A; Sisson G; Charlesworth A; Shaikh H; Bjornsson E; Heneghan MA
EBioMedicine; 2015 Oct; 2(10):1523-7. PubMed ID: 26629548
[TBL] [Abstract][Full Text] [Related]
45. Clinical course of primary sclerosing cholangitis and concomitant ulcerative colitis - a preliminary report of retrospective study among patients from Southern Poland.
Głowacki MK; Zwolińska-Wcisło M; Frączek P; Gomulska M; Owczarek D; Cibor D; Cieśla A; Mach T
Folia Med Cracov; 2015; 55(2):61-8. PubMed ID: 26839244
[TBL] [Abstract][Full Text] [Related]
46. The characteristics of pediatric ulcerative colitis with primary sclerosing cholangitis: A single-center study in Taiwan.
Chien MM; Chang MH; Chang KC; Chiu YC; Chen HL; Hsu HY; Wu JF
Pediatr Neonatol; 2021 Sep; 62(5):483-490. PubMed ID: 34074613
[TBL] [Abstract][Full Text] [Related]
47. Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis.
Braden B; Halliday J; Aryasingha S; Sharifi Y; Checchin D; Warren BF; Kitiyakara T; Travis SP; Chapman RW
Clin Gastroenterol Hepatol; 2012 Mar; 10(3):303-8. PubMed ID: 22037429
[TBL] [Abstract][Full Text] [Related]
48. Impaired Hepatic Adaptation to Chronic Cholestasis induced by Primary Sclerosing Cholangitis.
Milkiewicz M; Klak M; Kempinska-Podhorodecka A; Wiechowska-Kozlowska A; Urasinska E; Blatkiewicz M; Wunsch E; Elias E; Milkiewicz P
Sci Rep; 2016 Dec; 6():39573. PubMed ID: 28008998
[TBL] [Abstract][Full Text] [Related]
49. Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4.
Ellinghaus D; Folseraas T; Holm K; Ellinghaus E; Melum E; Balschun T; Laerdahl JK; Shiryaev A; Gotthardt DN; Weismüller TJ; Schramm C; Wittig M; Bergquist A; Björnsson E; Marschall HU; Vatn M; Teufel A; Rust C; Gieger C; Wichmann HE; Runz H; Sterneck M; Rupp C; Braun F; Weersma RK; Wijmenga C; Ponsioen CY; Mathew CG; Rutgeerts P; Vermeire S; Schrumpf E; Hov JR; Manns MP; Boberg KM; Schreiber S; Franke A; Karlsen TH
Hepatology; 2013 Sep; 58(3):1074-83. PubMed ID: 22821403
[TBL] [Abstract][Full Text] [Related]
50. Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation.
Wu N; Meng F; Zhou T; Han Y; Kennedy L; Venter J; Francis H; DeMorrow S; Onori P; Invernizzi P; Bernuzzi F; Mancinelli R; Gaudio E; Franchitto A; Glaser S; Alpini G
FASEB J; 2017 Oct; 31(10):4305-4324. PubMed ID: 28634212
[TBL] [Abstract][Full Text] [Related]
51. Clinical Course of Ulcerative Colitis After Liver Transplantation in Patients with Concomitant Primary Sclerosing Cholangitis and Ulcerative Colitis.
Fattahi MR; Malek-Hosseini SA; Sivandzadeh GR; Safarpour AR; Bagheri Lankarani K; Taghavi AR; Ejtehadi F
Inflamm Bowel Dis; 2017 Jul; 23(7):1160-1167. PubMed ID: 28520586
[TBL] [Abstract][Full Text] [Related]
52. Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?
Marelli L; Xirouchakis E; Kalambokis G; Cholongitas E; Hamilton MI; Burroughs AK
Gut; 2011 Sep; 60(9):1224-8. PubMed ID: 21402617
[TBL] [Abstract][Full Text] [Related]
53. Unique Inflammatory Bowel Disease Phenotype of Pediatric Primary Sclerosing Cholangitis: A Single-Center Study.
Shiau H; Ihekweazu FD; Amin M; Fofanova T; Miloh T; Kellermayer R
J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):404-409. PubMed ID: 28141677
[TBL] [Abstract][Full Text] [Related]
54. Increased Active Inflammation in the Colon is Not a Reliable Predictor of an Elevated Risk of Dysplasia in Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis.
Zhang R; Wang D; Lauwers GY; Choi WT
Am J Surg Pathol; 2024 May; ():. PubMed ID: 38809303
[TBL] [Abstract][Full Text] [Related]
55. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis.
Marchesa P; Lashner BA; Lavery IC; Milsom J; Hull TL; Strong SA; Church JM; Navarro G; Fazio VW
Am J Gastroenterol; 1997 Aug; 92(8):1285-8. PubMed ID: 9260790
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis.
Dubois-Camacho K; Diaz-Jimenez D; De la Fuente M; Quera R; Simian D; Martínez M; Landskron G; Olivares-Morales M; Cidlowski JA; Xu X; Gao G; Xie J; Chnaiderman J; Soto-Rifo R; González MJ; Calixto A; Hermoso MA
Front Immunol; 2019; 10():2449. PubMed ID: 31824476
[TBL] [Abstract][Full Text] [Related]
57. [Increased neoplastic risks in ulcerative colitis associated with primary sclerosing cholangitis].
Kouam C; Warling O; Van Kemseke C; Loly JP; Louis E; Delwaide J
Rev Med Liege; 2020 Nov; 75(11):724-730. PubMed ID: 33155446
[TBL] [Abstract][Full Text] [Related]
58. Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis.
Hov JR; Keitel V; Laerdahl JK; Spomer L; Ellinghaus E; ElSharawy A; Melum E; Boberg KM; Manke T; Balschun T; Schramm C; Bergquist A; Weismüller T; Gotthardt D; Rust C; Henckaerts L; Onnie CM; Weersma RK; Sterneck M; Teufel A; Runz H; Stiehl A; Ponsioen CY; Wijmenga C; Vatn MH; ; Stokkers PC; Vermeire S; Mathew CG; Lie BA; Beuers U; Manns MP; Schreiber S; Schrumpf E; Häussinger D; Franke A; Karlsen TH
PLoS One; 2010 Aug; 5(8):e12403. PubMed ID: 20811628
[TBL] [Abstract][Full Text] [Related]
59. Whole Exome Sequencing Identifies Two Novel Mutations in a Patient with UC Associated with PSC and SSA.
Wu D; Chen D; Shi W; Liu W; Zhou W; Qian J
Can J Gastroenterol Hepatol; 2021; 2021():9936932. PubMed ID: 34545326
[TBL] [Abstract][Full Text] [Related]
60. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis.
Shetty K; Rybicki L; Brzezinski A; Carey WD; Lashner BA
Am J Gastroenterol; 1999 Jun; 94(6):1643-9. PubMed ID: 10364038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]